https://www.selleckchem.com/pr....oducts/navoximod.htm
Gastric cancer (GC) is mostly diagnosed at advanced stage, so prognosis is poor. Therefore, it is necessary to understand the molecular mechanism of GC development to design new targeted treatment to improve the prognosis of gastric cancer patients. To assess the prognostic value of NEDD-9 and FOXL-1 expression in intestinal type gastric cancer patients, as well as their relationship to clinicopathologic features of the disease and patients outcome. This is a retrospective study; we included 50 sections from formalin-fixed, paraffin-e
Like
Comment
Share
